Advanced Renal Cell Carcinoma (RCC) Management: An Expert Panel Recommendation From the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
Andrey Soares, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, Diogo Assed Bastos, Denis Leonardo Jardim, André Deeke Sasse, Adriano Gonçalves E Silva, André P Fay, Diogo Augusto Rodrigues da Rosa, Evanius Wierman, Fabio Kater, Fabio A Schutz, Fernando Nunes Galvão de Oliveira, Igor Alexandre Protzner Morbeck, José Augusto Rinck Jr, Karine Martins da Trindade, Manuel Caitano Maia, Vinicius Carrera Souza,
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis
Fernando Sabino M Monteiro, Andrey Soares, Márcio Debiasi, Fabio A Schutz, Fernando Cotait Maluf, Diogo Assed Bastos, Andre Sasse, Carolina G S Cauduro, Gabriela Oliveira Mendes, Patricia K Ziegelmann, André P Fay PMID: 32303427 DOI: 10.1016/j.clgc.2020.02.012 Full link: https://pubmed.ncbi.nlm.nih.gov/32410064/
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery
Stênio de Cássio Zequi, Walter Henriques da Costa, Fernando Korkes, Rodolfo Borges dos Reis, Wilson Francisco Schreiner Busato, Wagner Eduardo Matheus, Deusdedit Cortez Vieira da Silva Neto, Felipe de Almeida e Paula, Gustavo Franco Carvalhal, Lucas Nogueira, Roni de Carvalho Fernandes, Adriano Gonçalves e Silva, André Deeke Sasse, André P. Fay, Denis Leonardo Jardim, Diogo Assed Bastos, Diogo Augusto Rodrigues
Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
Marcelo Langer Wroclawski, Fabio A. Schutz, Jonathan Doyun Cha, and Andrey Soares J Glob Oncol. 2019 Aug;5:1-9. Full link: https://ascopubs.org/doi/full/10.1200/JGO.19.00112
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
Daniel Vargas Almeida, Cleyton Z. Oliveira, Andrey Soares, RODRIGO COUTINHO MARIANO, Denis L Jardim, Diogo Assed Bastos, Fernando C. Maluf, Gustavo Werutsky, Fernando Sabino M Monteiro, Vinicius Carrera Souza, Guillermo de Velasco, Andre P. Fay, Andre Deeke Sasse, Fabio A. B. Schutz ASCO 2019; J Clin Oncol 37, 2019 15_suppl.4579, published online only Full link: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.4579
The LACOG-0415 phase II trial: abirateroneacetate and ADT versus apalutamide versusabiraterone acetate and apalutamide inpatients with advanced prostate cancerwith non-castration testosterone levels
Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, Vinicius Carrera Souza, Suelen Patricia dos Santos Martins, Fábio Peixoto, Oren Smaletz, Fábio Schutz, Daniel Herchenhorn, Telma Santos, Flavio Mavignier Carcano, David Queiroz Muniz, Paulo R. S. Nunes Filho, Facundo Zaffaroni, Carlos Barrios and André FayBMC Cancer Full link: https://rdcu.be/bDXNy
Phase II randomized study of Abiraterone acetate plus ADT versus ARN 509 versus Abiraterone and ARN 509 in patients with advanced prostate cancer with non-castrate testosterone levels.
Fernando Maluf, Oren Smaletz, Fabio Schutz, Vinicius Carrera Souza, Andre Poisl Fay, Daniel Herchenhorn, Gustavo Werutsky, Telma Murias Santos ASCO GU 2018 Full link: https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.6_suppl.TPS404#affiliationsContainer